Video coverage from ELCC 2014 – The European Lung Cancer Conference

Lung adenocarcinoma with RET fusion: early experience with diagnosis and targeted therapy

O.Gautschi and L.Bubendorf discourse on the presence of RET aberrations in NSCLC; explain current diagnostic techniques and future screening possibilities; and call for more trials to validate use of promising targeted drugs, sending patients to active centres for broad testing.

ELCC 2014: Critical issues in the ever-changing field of thoracic malignancies

E.Felip & R.Dziadziuszko anticipate some topics of the European Lung Cancer Conference, co-organised by ESMO and IASLC: early drug development; toxicities and side-effects of targeted drugs; molecular testing; immunotherapies. Everything that lung cancer doctors should know.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings